MedTrace Logo

Zinc Absorption From Zinc Citrate, Zinc Gluconate and Zinc Oxide

NCT01576627 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2013-01-04

No results posted yet for this study

Summary

The goal of this trial is to evaluate zinc citrate, a zinc compound with promising sensory properties and a high zinc content, as an alternative zinc compound to be used for supplementation or food fortification. The bioavailability of zinc citrate given as a supplement to young Swiss adults will be assessed and compared to the bioavailability of the commonly used zinc compounds zinc gluconate and zinc oxide.

Conditions

  • Healthy

Interventions

DIETARY_SUPPLEMENT

zinc citrate

10 mg of zinc as either zinc citrate

DIETARY_SUPPLEMENT

Zinc Gluconate

10 mg of zinc as either zinc gluconate

DIETARY_SUPPLEMENT

Zinc oxide

10 mg of zinc as either zinc oxide

Sponsors & Collaborators

  • University of Zurich

    collaborator OTHER

  • Prof. Michael B. Zimmermann

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
QUADRUPLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2012-05-31
Completion
2012-11-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01576627 on ClinicalTrials.gov